Terpenia Phytotherapeutics Email Formats

About Terpenia Phytotherapeutics

Terpenia pioneers intellectual property (IP) in innovative cannabis medications through in-house research, formulation, trials, and pharmaceutical approval. Our focus on IP drives the development of natural, effective cannabinoid-based treatments, revolutionizing patient care with personalized approaches. We produce organic full-spectrum cannabis extracts and flowers in full compliance with EU standards and regulations. Our 2.340m² greenhouse in northern Greece is dedicated to cultivating purely organic medical cannabis, with meticulous attention to plant genetics and active ingredient content. Our global distribution network includes wholesalers, pharmaceutical companies, and research facilities. Adjacent to our greenhouse, our extraction facility produces full-spectrum extracts rich in cannabinoids, terpenes, and flavonoids, ensuring consistent active ingredient content for safe and flexible dosages. Although THC is a key component of our extracts, our R&D focuses on developing compounds with reduced psychotropic side effects for medical use. Our operations are guided by an environmental code of conduct, integrating ecological, social, and knowledge management aspects into all activities. Our team comprises internationally acclaimed experts in medicine, molecular biomedicine, and botany.

View contact profiles from Terpenia Phytotherapeutics